For its first quarter, Zoetis earned revenue of $2.2 billion, which was a 10% improvement over the same period of 2023. Non- ...

Zoetis (NYSE:ZTS) shares spiked on Thursday after the animal health company posted better-than-expected financials for Q1 ...

Stifel raised the price target for the Zoetis Inc (NYSE:ZTS) stock to “a Buy”. The rating was released on January 12, 2024, according to finviz. The research report from Exane BNP Paribas has ...

The temporary problems facing Zoetis could create an incredible opportunity for investors thinking decades ahead.

Zoetis (ZTS) reports better-than-expected first-quarter results, wherein both earnings and revenues beat estimates. Shares ...

Zoetis, a leading animal health company, shows impressive revenue growth despite drug safety concerns. Click here to read my ...

Phibro Animal Health Corporation's deal with Zoetis looks promising, but lackluster performance over many years leaves room ...

PARSIPPANY, N.J. & TEANECK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) and Phibro Animal Health Corporation (Nasdaq: PAHC) ...

Zoetis Inc. (NYSE:ZTS) has been named to Fair360’s Top 50 Companies list for the first time, underscoring the company’s ...

Zoetis reported a 10% Y/Y revenue increase to $2.190 billion, driven by strong performance in the U.S. segment, with sales up ...

By Colin Kellaher Zoetis has inked a deal to sell its medicated-feed-additive product portfolio to fellow animal-health company Phibro Animal Health for ...